株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中東・北アフリカ (MENA) におけるライフサイエンス産業の展望・予測 (~2020年)

Middle East and North Africa (MENA) Life Sciences Industry Outlook, Forecast to 2020

発行 Frost & Sullivan 商品コード 910105
出版日 ページ情報 英文 42 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
中東・北アフリカ (MENA) におけるライフサイエンス産業の展望・予測 (~2020年) Middle East and North Africa (MENA) Life Sciences Industry Outlook, Forecast to 2020
出版日: 2019年08月23日 ページ情報: 英文 42 Pages
概要

現地製造の拡大および生活習慣病への政府支出の増加は、2020年における主要な市場成長の促進要因となる見込みです。中東・北アフリカ (MENA) におけるライフサイエンス市場規模は、2020年までに400億米ドルを上回ると予測されています。

当レポートでは、中東・北アフリカ (MENA) におけるライフサイエンス産業について調査し、市場の概要と予測、収益予測、セグメント別の予測、主な動向と成長機会、戦略的提言と将来の展望などについてまとめています。

エグゼクティブサマリー

MENAのライフサイエンス市場の主な予測

  • 予測1:医薬品製造のローカライゼーション
  • 予測2:NGS試験の認識・導入の拡大
  • 予測3:中東における糖尿病やその他生活習慣病に対する予算の上昇

各国の予測

  • KSA (サウジアラビア)
  • UAE (アラブ首長国連邦)
  • クウェート
  • エジプト
  • アルジェリア
  • モロッコ

医薬品・バイオテクノロジー部門の展望

  • 市場概要
  • 主な成長機会
  • 注目企業

IVD部門の展望

  • 市場概要
  • 主な成長機会
  • 注目企業

結論

付録

Frost & Sullivanについて

目次
Product Code: PA76-52

Increased Local Manufacturing and Government Spending on Lifestyle Diseases to be Key Driving Factors in 2020

In this research deliverable, Frost & Sullivan's analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region's life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transpire over 2019 and 2020 as organizations prepare for the future. This study provides guidance on where to find the greatest opportunities for expansion and which key companies to look out for.

Frost & Sullivan projects the MENA Life Sciences market to cross US$ 40 billion by 2020. A shift in the focus of healthcare towards lifestyle-driven chronic health conditions and an increasingly affluent population's preference for research-based branded drugs and preventive screening diagnostic tests are expected to drive the MENA life sciences market during the forecast period (2019 to 2020). Ongoing economic diversification and localization efforts by governments will make the domestic production of branded generic drugs more important than ever for both local consumption and export services. In addition, the regulatory environment will see a major transformation in each country. Given the on-going localization trends, it will be critical for global pharma MNCs to strategically collaborate with local agents or CMOs for their expertise on domestic contacts, customs regulations, and faster time to market in the MENA region. Areas exhibiting high growth opportunities will be the main focus of governments and industries alike. Business models specific to MENA will be pursued in contrast to those in larger markets of developed nations. Mergers and acquisitions are expected as stakeholders collaborate to achieve common outcomes. The outlook foresees increased collaboration and M&A activities between the life sciences and other healthcare sectors, in which preventative digital technology innovations will support the prevention of the onset of chronic and genetic diseases. Health spending is expected to rise in the region with governments aiming to meet sustainable development goals.

Research Highlights:

  • Market overview and projections for the MENA life sciences market in 2020
  • Revenue forecast by key MENA life sciences markets
  • Key predictions for the life sciences market in 2020 by segment
  • Key trends and growth opportunities affecting the MENA life sciences market
  • Strategic recommendations and future outlook of the life sciences market

Key Issues Addressed:

  • What are the key predictions for the 2020 MENA life sciences market?
  • What is the market projection for MENA pharmaceutical/biotechnology and IVD markets for 2020?
  • Which are the most preferred countries in MENA for the localization of future drug manufacturing activities?
  • What are key growth opportunities in the MENA pharma and IVD industry for 2020?
  • Who are the companies to watch in the MENA region for the life sciences market?
  • What policies and regulatory developments will affect your company's MENA operations in 2020?
  • What are the monetization opportunities for the life science industry as major GCC countries aim to diversify towards a service-based economy?

Table of Contents

Executive Summary

  • Key 2020 MENA Life Sciences Predictions
  • Research Scope
  • MENA Life Sciences Industry Revenue, 2018-2020
  • 2020 MENA Regional Life Sciences Perspective

Key 2020 MENA Life Sciences Market Predictions

  • Prediction 1-Localization of Pharma Manufacturing
  • Prediction 2-NGS Testing Awareness and Adoption Increases
  • Prediction 3-Rise in Middle East Budget for Diabetes and Other Lifestyle Disorders

Country Predictions 2020

  • 2020 MENA Healthcare Life Sciences Predictions-KSA
  • 2020 MENA Healthcare Predictions-UAE
  • 2020 MENA Healthcare Predictions-Kuwait
  • 2020 MENA Healthcare Predictions-Egypt
  • 2020 MENA Healthcare Predictions-Algeria
  • 2020 MENA Healthcare Predictions-Morocco

Pharmaceuticals and Biotechnology Sector Outlook 2020

  • 2020 Market Snapshot-Pharmaceuticals and Biotechnology
  • Key Growth Opportunities-Pharmaceuticals and Biotechnology
  • 2020 Companies to Watch-Pharmaceuticals and Biotechnology

IVD Sector Outlook 2020

  • 2020 Market Snapshot-IVD
  • Key Growth Opportunities-IVD
  • 2020 Companies to Watch-IVD

Concluding Thoughts

  • Concluding Thoughts
  • Legal Disclaimer

Appendix

  • Market Definitions-Pharmaceuticals and Biotechnology
  • Market Definitions-IVD
  • List of Exhibits

The Frost & Sullivan Story

  • The Frost & Sullivan Story
  • Value Proposition-Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360º Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top